CHICAGO — Chimeric antigen receptor T-cell therapy has exhibited “compelling” efficacy and safety in lupus, allowing 84% of patients to cease other immunosuppressive drugs through follow-up, according ...

This living topic provides a comprehensive overview of recent developments affecting everyday consumers. It includes a variety of news articles on topics such as product recalls, financial scams, new ...

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.